Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 4753 Reports

🤖 AI Analyzed

Recent

📄 Page 276 of 397

UWHARRIE CAPITAL CORP

10-K March 5, 2026

Key Highlights

Strong financial performance in 2023 with $15.2 million net income and $2.10 EPS...
Robust capital position with a 12.5% CET1 ratio, exceeding regulatory requiremen...
Strategic focus on organic growth, enhancing digital banking capabilities, and e...

Read Analysis

🤖 AI Generated

Clarus Corp

10-K March 5, 2026

Key Highlights

Strong portfolio of established outdoor and consumer brands, including Black Dia...
Achieved $450 million in net sales, a 5% increase year-over-year, primarily driv...
Significant digital expansion, with direct-to-consumer (DTC) e-commerce now acco...

Read Analysis

🤖 AI Generated

SOLITARIO RESOURCES CORP.

10-K March 5, 2026

Key Highlights

Strong financial runway with approximately $12.5 million in cash and no signific...
Successful expansion of its early-stage portfolio with the acquisition of two ne...
Continued advancement of major projects (Florida Canyon, Lik) through partner fu...

Read Analysis

🤖 AI Generated

NOKIA CORP

20-F March 5, 2026

Key Highlights

Nokia operates a diversified business across Mobile Networks, Network Infrastruc...
The company serves key customer segments including Telecom Providers, Enterprise...
A significant leadership transition is underway, with Justin Hotard set to succe...

Read Analysis

🤖 AI Generated

SMITH MICRO SOFTWARE, INC.

10-K March 5, 2026

Key Highlights

Achieved massive revenue growth across key segments, including a 380% jump in Li...
Strong demand for its primary products, especially within the Family Safety segm...
Strategic divestiture of the ViewSpot product generated a gain, signaling a stre...

Read Analysis

🤖 AI Generated

Riley Exploration Permian, Inc.

10-K March 4, 2026

Key Highlights

Achieved strong financial performance in 2025 with significant revenue and net i...
Expanded Permian Basin footprint through strategic acquisitions, including Silve...
Demonstrated robust operational metrics, including increased production volumes ...

Read Analysis

🤖 AI Generated

COMPX INTERNATIONAL INC

10-K March 4, 2026

Key Highlights

Strong financial health with $35.8 million in cash and a 3.2x current ratio.
Security Products segment grew 5.8% to $98.5 million, driven by new electronic l...
Recognized as a North American market leader in cabinet locks, known for quality...

Read Analysis

🤖 AI Generated

OIL STATES INTERNATIONAL, INC

10-K March 4, 2026

Key Highlights

Significant financial turnaround in 2024, moving from a net loss to $45 million ...
Achieved 5% revenue growth to $1.15 billion and a 15% increase in Adjusted EBITD...
Secured long-term deepwater project contracts and successfully launched new prop...

Read Analysis

🤖 AI Generated

WESTWOOD HOLDINGS GROUP INC

10-K March 4, 2026

Key Highlights

Strategic review launched focusing on cost optimization, operational efficiency,...
Plans to explore product diversification, particularly in alternative investment...
Management aims to return to profitability in 2025 through aggressive cost manag...

Read Analysis

🤖 AI Generated

SCYNEXIS INC

10-K March 4, 2026

Key Highlights

Positive Phase 3 results and sNDA submission for Brexafemme's expanded indicatio...
Significant revenue growth in 2025, reaching $15.5 million, driven by Brexafemme...
Secured a new European commercialization agreement for Brexafemme, accelerating ...

Read Analysis

🤖 AI Generated

GRAN TIERRA ENERGY INC.

10-K March 4, 2026

Key Highlights

Returned to profitability with $80 million net income in 2025, a significant imp...
Strategically optimized portfolio through $80 million in divestitures and $40 mi...
Generated robust cash flow from operating activities of $350 million, funding ca...

Read Analysis

🤖 AI Generated

Cellectar Biosciences, Inc.

10-K March 4, 2026

Key Highlights

PCLX-001, their lead product candidate, successfully completed patient enrollmen...
Received FDA Orphan Drug Designation for PCLX-001 for a specific rare cancer ind...
Proprietary Phospholipid Drug Conjugate (PDC) platform offers a targeted cancer ...

Read Analysis

🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage